Alnylam Pharmaceuticals, Inc. (ALNY) vs Labcorp Holdings Inc. (LH)
A side-by-side comparison of Alnylam Pharmaceuticals, Inc. and Labcorp Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 30, 2026. Differences are shown without an overall score or investment verdict.
ALNY
Alnylam Pharmaceuticals, Inc.
$205.48HealthcareDelayed quote: Jul 30, 2026, 4:00 PM EDT
LH
Labcorp Holdings Inc.
$315.53HealthcareDelayed quote: Jul 30, 2026, 4:00 PM EDT
Total return — ALNY vs LH
growth of $100 · dividends reinvested · last 22yALNY +4698.8%LH +841.2%ALNY compounded faster
Log scale — wide-divergence pair
ALNY LH
ALNY vs LH: by the numbers
- •ALNY is the larger company ($27.43B vs $25.87B market cap).
- •LH trades at the lower trailing earnings multiple (27.21 vs 34.71 P/E), one valuation lens rather than an overall verdict.
- •ALNY converts more revenue to profit (16.82% vs 6.66% net margin).
- •ALNY grew revenue faster over the past five years (47.53% vs -1.58% CAGR).
- •LH pays a dividend (0.94% yield), while ALNY has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | ALNY | LH |
|---|---|---|
| P/E ratio | 34.71 | 27.21 |
| Forward P/E | 27.69 | 17.04 |
| P/S ratio | 5.91 | 1.80 |
| P/B ratio | 20.98 | 2.92 |
| PEG ratio | N/A | 1.28 |
| EV / EBITDA | 27.23 | 14.11 |
| FCF yield | 2.79% | 5.43% |
Profitability
| Metric | ALNY | LH |
|---|---|---|
| Gross margin | 81.77% | 27.79% |
| Operating margin | 20.81% | 11.03% |
| Net margin | 16.82% | 6.66% |
| ROE | 59.67% | 10.79% |
| ROIC | 13.74% | 7.39% |
Dividends
| Metric | ALNY | LH |
|---|---|---|
| Dividend yield | N/A | 0.94% |
| Payout ratio | N/A | 27.32% |
Growth (annualized)
| Metric | ALNY | LH |
|---|---|---|
| Revenue CAGR (5Y) | 47.53% | -1.58% |
| EPS CAGR (5Y) | N/A | -8.00% |
| FCF CAGR (5Y) | 15.55% | -12.63% |
| Total return CAGR (5Y) | 2.80% | 5.02% |
Frequently asked
- Which has the lower trailing P/E, ALNY or LH?
- LH has the lower trailing P/E: ALNY trades at 34.71 and LH at 27.21. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ALNY or LH?
- Over the past five years, ALNY grew revenue faster — ALNY at a 47.53% CAGR versus LH at -1.58%.
- Does ALNY or LH pay a bigger dividend?
- LH pays a dividend (0.94% yield), while ALNY has no payments in the available dividend history.
- Is ALNY or LH more profitable?
- ALNY runs the higher net margin — ALNY at 16.82% versus LH at 6.66%.
- How have ALNY and LH total returns compared?
- Over the past 10 years, ALNY delivered 11.68% and LH delivered 10.43% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Alnylam Pharmaceuticals P/E ratioLabcorp P/E ratioAlnylam Pharmaceuticals dividend yieldLabcorp dividend yieldAlnylam Pharmaceuticals ROELabcorp ROEAlnylam Pharmaceuticals operating marginLabcorp operating marginAlnylam Pharmaceuticals revenue growthLabcorp revenue growthAlnylam Pharmaceuticals free cash flowLabcorp free cash flow
Alnylam Pharmaceuticals & Labcorp appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 30, 2026.